Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Residual Limb Hyperhidrosis
NCT03236012Phase 1Completed
- Sponsor
- University of Utah
- Start
- Jan 2019
- Primary completion
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of botulinum toxin type A in hyperhidrosis, sponsored by University of Utah. Primary endpoint: Hyperhidrosis Disease Severity Scale at 20 weeks. Started Jan 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hyperhidrosis
Beyond the preview
Go deeper on NCT03236012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03236012.